Education
About Us
Working with TipRanks
Follow Us
Apyx Medical Corporation (APYX)
NASDAQ:APYX
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.12Last Year’s EPS
-0.22Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 13, 2025
|% Change Since: 16.82%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there were several positive developments such as strong advanced energy segment performance, successful marketing campaigns, and cost-saving initiatives, the decline in overall revenue, OEM segment sales, and international revenue, coupled with market challenges from GLP-1 drug adoption, present notable challenges.Company Guidance
During the Apyx Medical fourth quarter and full year 2024 conference call, the company provided guidance for the 2025 fiscal year. Apyx expects total revenue to range between $47.6 million and $49.0 million, compared to $48.1 million in 2024. Advanced Energy segment revenue is projected to be between $39.6 million and $41.0 million, while OEM segment sales are expected at approximately $8 million, down from $9.5 million in 2024. The company anticipates maintaining a gross profit margin of approximately 60% for the year and expects total operating expenses to not exceed $40 million. Additionally, Apyx foresees cash sustainability until 2027, supported by the projected uptake of their new AYON Body Contouring System, which is set for a soft launch in the latter half of 2025, pending FDA clearance.Advanced Energy Segment Performance
Sales of advanced energy products exceeded expectations at $12.1 million for Q4, showing a 30% sequential growth compared to Q3 2024.
Successful Direct-to-Consumer Campaign
The direct-to-consumer marketing campaign surpassed media placement goals by 187% and exceeded impressions goal by over 13,000%, significantly increasing brand awareness and consumer demand.
AYON Body Contouring System Development
The AYON Body Contouring System was submitted to the FDA 90 days ahead of schedule, with a planned launch in the back half of 2025, which is expected to boost equipment sales growth.
Cost Reduction and Restructuring
A restructuring program that reduced the U.S. workforce by 25% is expected to save approximately $4.3 million annually, with additional cost savings identified.
Improved Financial Metrics
Operating expenses decreased from $14.7 million to $12 million, and the net loss attributable to stockholders decreased from $9.6 million to $4.6 million year-over-year.
---
APYX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
APYX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 13, 2025 | $1.07 | $1.04 | -2.80% |
| Nov 08, 2024 | $1.22 | $1.52 | +24.59% |
| Aug 08, 2024 | $1.02 | $1.04 | +1.96% |
| May 09, 2024 | $1.35 | $1.66 | +22.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Apyx Medical Corporation (APYX) report earnings?
Apyx Medical Corporation (APYX) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Apyx Medical Corporation (APYX) earnings time?
Apyx Medical Corporation (APYX) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is APYX EPS forecast?
APYX EPS forecast for the fiscal quarter 2025 (Q1) is -0.12.
---